Test Bank for Basic Pharmacology for Nurses 14th edition by Clayton, Stock and Harroun
|
|
- Dylan Watson
- 6 years ago
- Views:
Transcription
1 Test Bank for Basic Pharmacology for Nurses 14th edition by Clayton, Stock and Harroun Link download full: Chapter 01: Definitions, Names, Standards, and Information Sources MULTIPLE CHOICE 1.The name is the name under which the drug is listed by the United States Food and Drug Administration, who by federal law names the drug for human use in the United States. 1. brand 3. official 2. nonproprietary 4. trademark ANS: 3 3. The official name is the name under which a drug is listed by the FDA. 1. The brand name, or trademark, is the name given to a drug by its manufacturer. 2. The nonproprietary, or generic, name is provided by the USAN Council. 4. The trademark, or brand name, is the name given to a drug by its manufacturer. PTS: 1 DIF: Cognitive Level: Knowledge REF: PAGE: 2
2 MSC:NCLEX Client Needs Category: Safe, Effective Care Environment 2.The contains information specific to nutritional supplements. 1. USP Dictionary of USAN & International Drug Names 2. Natural Medicines Comprehensive Database 3. United States Pharmacopoeia/National Formulary 4. Drug Interaction Facts ANS: 3 3. The United States Pharmacopoeia/National Formulary contains information specific to nutritional supplements. 1. USP Dictionary of USAN & International Drug Names is a compilation of drug names, pronunciation guide and possible future FDA-approved drugs; it does not include nutritional supplements. 2. Natural Medicines Comprehensive Database contains evidence-based information on herbal medicines and herbal combination products; it does not include information specific to nutritional supplements. 4. Drug Interaction Facts contains comprehensive information on drug interaction facts; it does not include nutritional supplements. PTS: 1 DIF: Cognitive Level: Knowledge REF: PAGE: 3 3.Drugs may be classified according to which of the following? 1. Effect on the body system 3. Generic or trade 2. Cost 4. Chemical constitution ANS: 1
3 1. Classification is according to effect on body system, therapeutic use or clinical indications, physiological or chemical action, prescription or nonprescription, and/or recreational drugs. 2. Drugs are not classified by cost. 3. Drugs are not classified by generic or trade names. 4. Drugs are not classified by chemical constitution. PTS: 1 DIF: Cognitive Level: Knowledge REF: PAGE: 2 4.The most comprehensive reference available to research a drug interaction is: 1. Drug Facts and Comparisons. 2. Drug Interaction Facts. 3. Handbook on Injectable Drugs. 4. Martindale The Complete Drug Reference. ANS: 2 2. First published in 1983, this reference is currently the most comprehensive book available on drug interactions. In addition to monographs listing various aspects of drug interactions, this information is reviewed and updated by an internationally renowned group of physicians and pharmacists with clinical and scientific expertise. 1. This is not the most comprehensive source. 3. This is not the most comprehensive source. 4. This is not the most comprehensive source. PTS: 1 DIF: Cognitive Level: Comprehension REF: PAGE: 4
4 5.The physician has written an order for a drug with which the nurse is unfamiliar. Which section of the Physician s Desk Reference would be most helpful to get information about this drug? 1. Manufacturer s section 3. Product Category section 2. Brand and Generic Name section 4. Product Information section ANS: 2 2. A physician s order would include the brand and/or generic name of the drug. The alphabetic index in the PDR would make this section the most user-friendly. Based on a physician s order, manufacturer s information and classification information would not be known. 1. This is a roster of manufacturers. 3. This lists products subdivided by therapeutic classes, such as analgesics, laxatives, oxytocics, and antibiotics. 4. This section contains reprints of the package inserts for the major products of manufacturers. PTS: 1 DIF: Cognitive Level: Knowledge REF: PAGE: 6 TOP:Nursing Process Step: Planning 6.A patient who lives in Atlanta states she s concerned she is taking an inferior antibiotic because her insurance company pays only for generic equivalents. A reference source to refer her to is: 1. Advice for the Patient (USPDI). 2. Therapeutic Choices. 3. Approved Drug Products and Legal Requirements (USPDI).
5 4. Drug Interaction Facts. ANS: 3 3. The United States Pharmacopoeia Dispensing Information is an excellent nontechnical source for patients. The Approved Drug Product and Legal Requirement section lists the therapeutic equivalent drugs when a drug is made by more than one manufacturer. Therefore, patients are able to verify therapeutic equivalence of the medication of lower cost. 1. This section features easy-to-understand, in-depth materials to help educate patients about medications and their proper use. 2. This is a Canadian publication. 4. This contains only information on drug interactions. PTS: 1 DIF: Cognitive Level: Knowledge REF: PAGE: 9 TOP:Nursing Process Step: Implementation 7.The Federal Drug Administration of the Department of Health and Human Services was given the authority to determine the safety of a drug before its marketing as a result of the: 1. Federal Food, Drug & Cosmetic Act (1938). 2. Durham-Humphrey Amendment (1952). 3. Controlled Substances Act (1970). 4. Kefauver-Harris Drug Amendment (1962). ANS: 1 1. The Federal Food, Drug & Cosmetic Act in 1938 authorized the FDA to determine the safety of all drugs before marketing. Later amendments and acts helped tighten FDA control and ensure drug safety. 2. This amendment defines the kinds of drugs that cannot be used safely without medical supervision and restricts their sale to prescription by a licensed practitioner.
6 3. This act addresses only controlled substances and their categorization. 4. The Kefauver-Harris Drug Amendments ensure drug efficacy and greater drug safety. Drug manufacturers are required to prove to the FDA the effectiveness of their products before marketing them. PTS: 1 DIF: Cognitive Level: Knowledge REF: PAGE: 9 8.A patient is receiving IM Demerol postoperatively. The nurse recognizes that this drug is a narcotic with a high potential for physical and psychological dependency. This drug will be locked up on the unit because it is a Schedule drug. 1. I 3. III 2. II 4. IV ANS: 2 2. Demerol (meperidine) is a Schedule II drug; it has a high potential for abuse and may lead to severe psychological and physical dependence. 1. Schedule I drugs have high potential for abuse and no recognized medical use. 3. Schedule II drugs have some potential for abuse. Use may lead to low-tomoderate physical dependence or high psychological dependence. 4. Schedule IV drugs have low potential for abuse. Use may lead to limited physical or psychological dependence. PTS: 1 DIF: Cognitive Level: Application REF: PAGE: 10 MSC:NCLEX Client Needs Category: Safe, Effective Care Environment
7 9.To expedite drug development and approval for an outbreak of smallpox, a disease for which there is no known treatment, the FDA would: 1. list smallpox as a health orphan disease. 2. omit the preclinical research phase. 3. extend the clinical research phase. 4. fast-track the investigational drug. ANS: 4 4. The FDA must ensure that all phases of the preclinical and clinical research phase have been completed in a safe manner. Once the Investigational New Drug Application has been approved, the drug can receive highest priority within the agency which is called fast tracking. A smallpox outbreak would become a priority concern in the world. 1. Orphan diseases are not researched in a priority manner. 2. Preclinical research is not omitted. 3. Extending any phase of the research would mean a longer time to develop a vaccine. PTS: 1 DIF: Cognitive Level: Knowledge REF: PAGE: 13 MSC:NCLEX Client Needs Category: Safe, Effective Care Environment 10.Over-the-counter (OTC) drugs may be purchased with: 1. a prescription from a physician. 2. a prescription from a health care provider licensed to prescribe medications. 3. no prescription. 4. a limited prescription specifying no refills. ANS: 3 3. Over-the-counter medications do not require a prescription.
8 1. Over-the-counter medications do not require a prescription. 2. Prescription drugs require an order by a health professional who is licensed to prescribe, such as a physician, nurse practitioner, physician assistant, or dentist. 4. Over-the-counter medications do not require a prescription. PTS: 1 DIF: Cognitive Level: Comprehension REF: PAGE: 2 TOP:Nursing Process Step: Planning 11.The most authoritative reference for medications that are injected is the: 1. Parenteral Drug Handbook. 3. Drugs and Injections Quarterly. 2. Handbook on Injectable Drugs. 4. Handbook of Nonprescription Drugs. ANS: 2 2. The Handbook on Injectable Drugs is the most comprehensive reference available on the topic of compatibility of injectable drugs. It is a collection of monographs for over 300 injectable drugs that are listed alphabetically by generic name. 1. Not all parenteral drugs are injected. 3. There is no reference by this name. 4. This has information about medications that do not require a prescription. PTS: 1 DIF: Cognitive Level: Comprehension REF: PAGE: 5 COMPLETION
9 1.Pharmacology deals with the study of drugs and their actions on. (Your response should appear as two words, lowercase, separated by a space.) ANS: living organisms Correct: Per definition. Incorrect: This is not the correct response. PTS: 1 DIF: Cognitive Level: Knowledge REF: PAGE: 1 TOP:Nursing Process Step: Evaluation MULTIPLE RESPONSE 1.The nurse is caring for a 5-year-old girl newly diagnosed with juvenile-onset diabetes mellitus. Which of the following approaches to therapeutic methods should be considered in treating this child and her illness? (Select all that apply.) 1. Therapeutic drugs 4. Regular daily exercise and activity 2. Concentrated carbohydrate diet 5. Daily baths 3. Family-centered care ANS: 1, 2, 4 1. Therapeutic methods include drug therapy. 2. Therapeutic methods include diet therapy. 4. Therapeutic methods include physiotherapy and psychological therapy. 3. Therapeutic methods do not include family-centered care.
10 5. Therapeutic methods do not include daily baths. PTS: 1 DIF: Cognitive Level: Application REF: PAGE: 1 TOP:Nursing Process Step: Planning 2.An 83-year-old woman experiencing shortness of breath is brought to the hospital by her daughter. The nurse is obtaining the medication history from the patient and her daughter. Unfortunately, neither have a list of her current medications, only a weekly pill dispenser that contains four different pills. They did not bring the prescription bottles with them, but they fill her prescriptions through the local pharmacy. Which of the following resources would be appropriate to use in determining the medication names and doses? (Select all that apply.) 1. Martindale The Complete Drug Reference 2. Physician s Desk Reference, grey section 3. Senior Citizens Center 4. Patient s home pharmacy 5. Drug Identification Guide ANS: 2, 4, 5 2. The Physician s Desk Reference, grey section, has full color images of commonly dispensed tablets and capsules. 4. The patient s pharmacy would have an accurate account of all the medications the client is currently on. 5. A Drug Identification Guide has full color images of commonly dispensed tablets and capsules. 1. Martindale The Complete Drug Reference has written information on medication and would not be an appropriate resource. 3. The Senior Citizens Center is not likely to have specific patient medication information.
11 PTS: 1 DIF: Cognitive Level: Analysis REF: PAGE: 6
Which was the greatest problem with patent medicines in early America that lead to drug legislation?
Pharmacology Connections to Nursing Practice 3rd Edition Adams Test Bank Full Download: http://testbanklive.com/download/pharmacology-connections-to-nursing-practice-3rd-edition-adams-test-bank/ Adams
More informationFlexRx 6-Tier. SM Pharmacy Benefit Guide
FlexRx 6-Tier SM Pharmacy Benefit Guide Welcome to FlexRx The AllWays Health Partners FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many
More informationNaloxone Expanded Access: OTC status Considerations for a Nonprescription Drug Development Program
Naloxone Expanded Access: OTC status Considerations for a Nonprescription Drug Development Program Andrea Leonard-Segal, M.D., M.S. Director, Division of Nonprescription Clinical Evaluation 1 Contents
More informationPharmacy benefit guide
FlexRx SM 5-Tier Pharmacy benefit guide 1 Welcome to FlexRx The NHP FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many common medications
More informationChloroform Codeine Ether
1 2 3 4 5 6 7 8 9 10 11 12 13 14 Chapter 6, Part 1 GENERAL PRINCIPLES OF PHARMACOLOGY Part 1 Basic Pharmacology Drugs are chemicals used to diagnose, treat, and disease. Pharmacology is the study of drugs
More informationChapter 1: Fundamentals of Pharmacology Test Bank
Chapter 1: Fundamentals of Pharmacology Test Bank MULTIPLE CHOICE 1. By which of the following routes are drugs administered directly into the bloodstream? a. Enteral b. Transdermal c. Transmucosal d.
More information6) One tablespoon is equivalent to how many milliliters?
Name Date 1) The patient has dropped off the prescription. In the diagram below what does the letter X represent in relation to workflow terminology? Drop Offà X à Fillà Verificationà Y a) Pickup b) Order
More informationFundamentals of Pharmacology for Veterinary Technicians Chapter 1
1906 1914 1933 1937 1938 1941 1951 1965 1968 1970 1970 1972 1972 1983 1984 1988 1994 1994 1996 1997 2001 2003 2008 The original Pure Food and Drug Act is passed by Congress on June 30 and signed by President
More informationH 7816 S T A T E O F R H O D E I S L A N D
LC00 01 -- H 1 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO BUSINESSES AND PROFESSIONS - PHARMACIES Introduced By: Representatives Serpa, Canario,
More informationCengage Learning. All rights reserved. No distribution allowed without express authorization. PART 1. Introduction to Pharmacologic Principles
PART 1 Introduction to Pharmacologic Principles 80333_01_ch01_p001-011 pp3.indd 1 5/5/10 9:51:20 PM Chapter 1 Consumer Safety and Drug Regulations Objectives Upon completion of this chapter, the learner
More informationCOPYRIGHTED MATERIAL. Introduction
1 Introduction Pharmacology is the science of drugs and their effects on biological systems. A drug can be defined as a chemical that can cause a change in a biological system; the important biological
More informationChanges to the Eighth Edition
Pharmacy Practice and the Law, Eighth Edition Includes Navigate 2 Advantage Access By Richard R. Abood, BS Pharm, JD-Professor Emeritus Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences,
More informationCHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY
CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY COMMUNITY PHARMACY OPERATIONS Technician Duties Related to Dispensing Over-the-Counter Drugs and
More informationCARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:
RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: CARD/MAIL/PRE-APPROVAL/PREFERRED The Prescription Drug Coverage under this Rider [replaces] [supplements] the Prescription
More informationSLEEP AIDS - LABELLING STANDARD
SLEEP AIDS - LABELLING STANDARD CATEGORY: DESCRIPTION: Sleep Aids An over-the-counter drug (tablet, capsule, caplet, powder, or elixir form) that is useful for the relief of occasional sleeplessness by
More information222 pain reliever from canada
Поиск 222 pain reliever from canada Pain Medications available from Canada Drugs Online. Toll free: 1-877-900-3784 Health Canada has issued new information concerning the use of ASA - caffeine - codeine.
More informationAPPROVED DRUG PRODUCTS with THERAPEUTIC EQUIVALENCE EVALUATIONS
APPROVED DRUG PRODUCTS WITH THERAPEUTIC EQUIVALENCE EVALUATIONS 34 th EDITION THE PRODUCTS IN THIS LIST HAVE BEEN APPROVED UNDER SECTION 505 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT. U.S. DEPARTMENT
More informationCHAPTER2 DRUG REGULATIONS
CHAPTER2 DRUG REGULATIONS Learning Outcomes: 1. Explain the role of patent medicines in the history of pharmacology and the legislation of drugs. Suggested Classroom Activity: Discuss with students how
More informationPharmacology for Pharmacy Technicians. Pharmacology. Pharmacology, cont'd. Fundamentals of Pharmacology
Pharmacology for Pharmacy Technicians Fundamentals of Pharmacology Pharmacology Pharmacy technicians have the skills to refill a prescription based on the patient s profile. Pharmacy technicians have good
More informationRE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements
Board Members Arizona State Board of Pharmacy 1616 W. Adams St., Suite 120 Phoenix, AZ 85007 c/o Kam Gandhi, PharmD Executive Director Arizona State Board of Pharmacy Via email: kgandhi@azpharmacy.gov
More informationMOATT Card-Style Version: A single page MOATT (PDF) is also available at the MASCC website.
MOATT V1.2 9/9/16 MOATT MASCC Teaching Tool for Patients Receiving Oral Agents for Cancer This teaching tool has been prepared to assist healthcare providers in the assessment and education of patients
More informationRequirements to the Registration of Medicinal products in the Republic of Armenia
Requirements to the Registration of Medicinal products in the Republic of Armenia Yerevan 2010 Requirements to the Registration of Medicinal products in the Republic of Armenia Current requirements to
More informationPHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998
PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998 Questions 1 20 are multiple choice; please record answers on Side 2 of a Standard Answer Sheet, Form 1158. Follow the instructions
More informationAbout the PCTB Examination Assisting the Pharmacist in Serving Patients p. 1 Filling the Medication Order p. 3 Receiving the Medication Order p.
Preface p. ix About the PCTB Examination p. xii Assisting the Pharmacist in Serving Patients p. 1 Filling the Medication Order p. 3 Receiving the Medication Order p. 4 The Retail Medication Order p. 6
More informationStudent Number. PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999
PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999 Questions 1-25 are multiple choice; please record answers on Side 2 of a Standard Answer Sheet, Form 1158. Follow the instructions
More informationLegal Considerations for. Immunizations
Legal Considerations for Pharamcists Providing Immunizations Gary G. Cacciatore, Pharm.D., J.D. Vice President of Regulatory Affairs and Associate Chief Regulatory Counsel Cardinal Health, Inc. 1 1 Outline
More informationDisclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations
49th Annual Meeting Non-Sterile Compounding/ Sunil Jambhekar, B. Pharm., M.S., Ph.D Professor, Pharmaceutical Sciences LECOM Bradenton, School of Pharmacy Bradenton, FL 34211 Disclosure I do not have a
More informationPROPOSED AMENDMENTS TO HOUSE BILL 3440
HB 0- (LC ) // (MBM/ps) Requested by Representative WILLIAMSON PROPOSED AMENDMENTS TO HOUSE BILL 0 1 On page 1 of the printed bill, line, delete 1A. and. Delete lines through and pages through and insert:
More informationJanuary 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9
January 19, 2018 Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9 By email: cannabis@canada.ca RE: Proposed Approach to the Regulation of Cannabis
More information4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch
Libia Lugo Drug Specialist San Juan District Office Investigations Branch The Food and Drug Administration (FDA) responsibilities extend to the 50 United States, the District of Columbia, Puerto Rico,
More informationCoventry Health Care of Georgia, Inc.
Coventry Health Care of Georgia, Inc. PRESCRIPTION DRUG RIDER (for High Deductible Health Plans) This Prescription Drug Rider is an attachment to the Coventry Health Care of Georgia, Inc. ( Health Plan
More informationPrescription Drug Options for Older Adults: Managing Your Medicines
Prescription Drug Options for Older Adults: Managing Your Medicines As people age, the likelihood of taking medicines increases; studies show that the more medicines people take, the more likely they are
More informationChapter Goal. Learning Objectives 9/11/2012. Chapter 5. Emergency Pharmacology
Chapter 5 Emergency Pharmacology Chapter Goal Understand basic principles of pharmacology, & develop drug profiles for common emergency medications Learning Objectives Differentiate among chemical, generic
More informationGetting started with Prime
Getting started with Prime How does a pharmacy plan work? When you visit your doctor, he or she may prescribe medicine for you. Here's how the plan works: Take your prescription and member ID card to the
More informationDRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT
c t DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to September 22, 2014. It is intended
More informationANTACID LABELLING STANDARD
ANTACID LABELLING STANDARD CATEGORY: DESCRIPTION: Antacid Single and multiple ingredient drugs, containing medicinal ingredients suitable for self-medication, which are intended to relieve symptoms such
More informationA. The burden of untreated pain. The importance of opioid therapy Potential pitfalls of opioid therapy
A. The burden of untreated pain. The importance of opioid therapy Potential pitfalls of opioid therapy The burden of untreated opioid addiction Medication assisted treatment Federal Regulation of MAT:
More informationGuidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.
Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry DRAFT GUIDANCE This guidance
More informationMedicines and Cosmetics Regulation Unvalidated References:
Medicines and Cosmetics Regulation 2002 Unvalidated References: This reprint of this Statutory Instrument incorporates all amendments, if any, made before 25 November 2006 and in force at 16 May 2002....
More informationGuideline for the Rational Use of Controlled Drugs
Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import
More informationhealth care quality Your Medicine: Play It Safe Medicine Record Form at the Learn more about how to take medicines safely. Use the
Your Medicine: Play It Safe Learn more about how to take medicines safely. Use the Medicine Record Form at the back of this booklet to keep track of your medicines. Logo Here health care quality Have you
More informationEMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC
EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC RAMI R KHOURY, MD, FACEP ASSISTANT MEDICAL DIRECTOR EMERGENCY CARE ALLEGIANCE HEALTH ADVERTISING AT ITS BEST! OVERDOSE
More informationMedicines and You: A Guide for Older Adults
Medicines and You: A Guide for Older Adults Council on Family Health Provided in cooperation with U.S. Department of Health and Human Services Food and Drug Administration and the Administration on Aging
More informationPREFACE. Saskatchewan is participating in the Common Drug Review (CDR).
PREFACE OBJECTIVES The Drug Plan has been established to: provide coverage to Saskatchewan residents for quality pharmaceutical products of proven therapeutic effectiveness; reduce the direct cost of prescription
More informationYour Medicine: Be Smart. Be Safe.
Your Medicine: Be Smart. Be Safe. Learn more about how to take medicines safely. Use the wallet card at the back of this booklet to keep track of your medicines. Keep this booklet with your medicines and
More informationGuideline on the Regulation of Therapeutic Products in New Zealand
Guideline on the Regulation of Therapeutic Products in New Zealand Part 10: Requirements for information for prescribers and consumers Edition 7.0 January 2016 Section 1: Legislation Section summary This
More informationSuggested Classroom Activity: Have the students access the FDA.gov website for the
Pharmacology for Nurses A Pathophysiologic Approach 5th Edition Adams SOLUTIONS MANUAL Full download at: https://testbankreal.com/download/pharmacology-for-nurses-apathophysiologic-approach-5th-edition-adams-solutions-manual/
More informationSub. S.B. 119 As Passed by the Senate
AM3404 Sub. S.B. 119 As Passed by the Senate Topic: Opioid Data and Communication Expansion Act moved to amend as follows: In line 1 of the title, after "4723.52," insert "4729.01, 4729.44, 4729.75, 4729.79,
More informationPrescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study
Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study Presented By: Scott McKibbin Special Advocate For Prescription Drugs State Of Illinois
More informationPharmacy Orientation PP150. Associate professor of Pharmaceutics Faculty of Pharmacy-Mansoura University
Pharmacy Orientation PP150 Associate professor of Pharmaceutics Faculty of Pharmacy-Mansoura University Lecture 1 Over-the-Counter (OTC) and Prescription Drugs Categories of Medicinal Products Three categories
More informationIssues for Part D Compliance
HCCA- MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE Issues for Part D Compliance Craig Miner, RPh, JD Division of Drug Plan Policy Babette S. Edgar, Pharm.D., MBA Division of Finance and Operations
More informationY. W. Francis Lam, Pharm.D. FCCP University of North Texas Health Science Center Grand Round Rx to OTC Switch: Potentials, Challenges, and Initiatives
1 Rx to OTC Switch Potentials, Challenges, and Initiatives Y. W. Francis Lam, Pharm.D., FCCP Professor of Pharmacology lamf@uthscsa.edu, 7-8355 Educational Goal Attendees will have an overall understanding
More informationSAFE MEDICATION USE FOR OLDER ADULTS
SAFE MEDICATION USE FOR OLDER ADULTS INFORMATION FOR OLDER ADULTS, FAMILIES, AND CAREGIVERS READ THIS PAMPHLET TO LEARN: Why it is Important to Understand and Know How to Manage your Medications. The Different
More informationMedication Use safety Training FOR SENIORS
www.mustforseniors.org Medication Use safety Training FOR SENIORS Medication Use Safety Training for Seniors A National Education Campaign for Older Adults and Caregivers developed by the National Council
More informationTHE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and
THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and effective. Before any drug is approved for marketing
More informationDo not open the test booklet prior to being told to do so.
Last Name: Pharmacy 4054 Pharmacy Law Exam II Do not open the test booklet prior to being told to do so. I, the undersigned student, agree to do my best on the exam and that I have only used resources
More information(A) A practitioner or by the practitioner's authorized agent in the practitioner's presence; or
First of 2 versions of this section 39-17-402. Definitions for this part and title 53, chapter 11, parts 3 and 4. [Effective until July 1, 2018. See the version effective on July 1, 2018.] As used in this
More informationCSS Perspective - Opioid Risk Management
Tufts Health Care Institute Program on Opioid Risk Management Risk Evaluation and Mitigation Strategy for Prescription Opioids: An In-Depth Review of Fundamental Issues CSS Perspective - Opioid Risk Management
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-THIRD REGULAR SESSION April 25-27, 2018 México D.F., México OEA/Ser.L/XIV.2.63 CICAD/doc.2377/18 25 April 2018 Original: Español MEASURES TO
More informationPHARMACY Section 9. Overview. Preferred Drug List. Additions and Exceptions to the Preferred Drug List
Overview The management of outpatient prescription drugs is an integral part of the medical management program to improve the health and well-being of our members. Prescriber and member involvement is
More informationRULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER 1140-17 DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS 1140-17-.01 Definitions 1140-17-.02 Purpose 1140-17-.03 Eligibility Criteria for Program Participation
More informationHistory Note: Authority G.S ; ; ; Eff. May 1, 1997; Amended Eff. January 1, 2015; March 1, 2013.
21 NCAC 46.1412 PHYSICAL REQUIREMENTS A health care facility pharmacy shall have sufficient floor space allocated to it to ensure that drugs are prepared in sanitary, well lighted, and enclosed places.
More informationPhysicians Public Duties and Responsibilities 2013 The McGraw-Hill Companies, Inc. All rights reserved.
Ch 9 Physicians Public Duties and Responsibilities Vital Statistics page 267 Vital events for which statistics are collected: Collected by government officials to assess population trends and needs Live
More informationIC ARTICLE 48. CONTROLLED SUBSTANCES
IC 35-48 ARTICLE 48. CONTROLLED SUBSTANCES IC 35-48-1 Chapter 1. Definitions IC 35-48-1-0.1 Application of certain amendments to chapter Sec. 0.1. The addition of section 9.3 of this chapter by P.L.225-2003
More informationCalifornia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile California Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationPharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.
Pharmacy Law 2016 Ronda H. Lacey, J.D., M.S. Pharm Disclosure Statement I have no conflicts of interest to disclose related to this presentation. Objectives At the conclusion of this continuing education
More informationIngredient Listing Qty. Unit NDC # Supplier ml
8/28/2016; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Progesterone 0.25%/Spironolactone 0.5% Stock Solution 5.00 ml Medisca Foamil Base 45.00 g Alcohol (95%), USP q.s. to
More informationDo Not Reproduce. Things to Tell Your Health Care Provider
Note: This CareKit does not replace expert medical care. 2 Things to Tell Your Health Care Provider Before medicine is prescribed, tell him or her: Medicines on your health plan s preferred drug list (formulary).
More informationNew Mexico. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile New Mexico Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationLouisiana. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationNorth Dakota Board of Pharmacy
North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives
More informationP1: SFL Printer: R.R. Donnelley China LWBK Pickett-3870G LWBK088-Pickett.cls June 9, :29. Part 1. General Principles of Pharmacology
Part 1 General Principles of Pharmacology 1 2 1 Introduction to Pharmacology: Role of Dental Hygienist, Regulations, and Sources of Information KEY TERMS Adverse effects: Unintended responses to a drug,
More informationReadopt with amendment Med 502, effective (Document #11090), to read as follows:
Adopted Rules 11-2-16 1 Readopt with amendment Med 502, effective 5-3-16 (Document #11090), to read as follows: PART Med 502 OPIOID PRESCRIBING Med 502.01 Applicability. This part shall apply to the prescribing
More informationLearning Outcomes 1. Identify key U.S. drug regulations that have provided guidelines for the safe and effective use of drugs and drug therapy.
CHAPTER 2 DRUG APPROVAL AND REGULATION Learning Outcomes 1. Identify key U.S. drug regulations that have provided guidelines for the safe and effective use of drugs and drug therapy. Suggested Classroom
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Transmucosal Immediate Release Fentanyl Products Reference Number: CP.CPA.211 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder
More informationPrescribing and Dispensing Drugs
STANDARDS & GUIDELINES Prescribing and Dispensing Drugs TABLE OF CONTENTS Standards and guidelines inform practitioners and the public of CDSBC s expectations for registrants. This document primarily contains
More informationMini PTCE Practice Exam
Mini PTCE Practice Exam Developed by the pharmacy educators at www.pharmtechpros.com This is a 33-question mini practice exam that gives you a taste of our full practice exam. This exam was created by
More informationFundamentals of Pharmacology
West Los Angeles College Worksheet #1 Fundamentals of Pharmacology Multiple Choice Identify the choice that best completes the statement or answers the question. 1. By which of the following routes are
More informationThe State Pharmacopoeia of the Russian Federation
The State Pharmacopoeia of the Russian Federation XII Edition Part 1 Current state and strategy for the future Before 12 th edition of the State Pharmacopoeia of the Russian Federation there were following
More informationPrescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks
Prescription Medication Guidelines for Medical Providers in CorVel s CorCare and Care IQ Networks Patient Health and Safety Guidelines Prescription Medications Policy Update / April 2017 In connection
More informationDepartment of Health and Human Services Food and Drug Administration 5600 Fishers Lane (HFI-40) Rockville, MD February 2000 (FDA)
Department of Health and Human Services Food and Drug Administration 5600 Fishers Lane (HFI-40) Rockville, MD 20857 February 2000 (FDA) 00-3237 Be More Careful With Medicines The Food and Drug Administration,
More informationJEOPARDY JEOPARDY JEOPARDY JEOPARDY JEOPARDY JEO RDY JEOPARDY JEOPARDY JEOPARDY JEOPARDY JEOPARDY
JEOPARDY JEOPARDY JEOPARDY JEOPARDY JEOPARDY JEO RDY JEOPARDY JEOPARDY JEOPARDY JEOPARDY JEOPARDY HERE ARE TODAY S CATEGORIES Brand/Generics Pharmacy Law Controlled Substances The Gastrointestinal System
More informationChapter 11 How to state your conditions clearly to the doctor
Chapter 11 How to state your conditions clearly to the doctor Chapter 11 How to state your conditions clearly to the doctor While seeing doctor, details of your statement should include the following:
More informationI am pleased to highlight for this Honourable House and the public. that today the Government will be laying amendments to the
MINISTERIAL STATEMENT TO THE HOUSE OF ASSEMBLY BY THE HONOURABLE KIM N. WILSON, JP, MP MINISTER OF HEALTH UPDATES AND MODERNIZATION OF DRUG SCHEDULES 24 November 2017 Mr Speaker and Honourable Members,
More informationSafe, effective, affordable drug choices: online tool for payers and patients.
Executive summary: Rising healthcare costs and greater access to medical information drive patients to seek options for their drug therapy. The MedAlternatives database by Gold Standard/Elsevier empowers
More informationDispensing and administration of emergency opioid antagonist without a
68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies
More informationEMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC
EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC RAMI R KHOURY, MD, FACEP ASSISTANT MEDICAL D IRECTOR EMERGENCY C A R E ALLEGIANCE HEALTH ADVERTISING AT ITS BEST! OVERDOSE
More informationFood and Drug Law. Fall Syllabus. Professor Jesson. Hamline University School of Law
Food and Drug Law Fall 2009 Syllabus Professor Jesson Hamline University School of Law General course Information: Course: Food and Drug Law Credits: 2 Classroom: Law 103 Time: Thursdays, 4-5:50 p.m. Professor:
More informationProposal To reclassify Beconase Hayfever (beclomethasone 50 g/actuation) from Restricted Medicine to Pharmacy Medicine
Beconase Hayfever (Beclomethasone dipropionate, 50 per actuation) Proposal To reclassify Beconase Hayfever (beclomethasone 50 g/actuation) from Restricted Medicine to Pharmacy Medicine Background to current
More informationHow Are Drugs Discovered?
DRUG EVALUATION & REGULATION M. Imad Damaj, Ph.D. Associate Professor Pharmacology and Toxicology Smith 656A, 828-1676, mdamaj@hsc.vcu.edu The Changed Context of Drug Discovery and Development The 1800s:
More informationThe Wisconsin Prescription Drug Monitoring Program
The Wisconsin Prescription Drug Monitoring Program DHS 2018 WI Opioid Forum April 12, 2018 Learning Objectives 1. How the WI epdmp supports healthcare professionals in making informed prescribing, dispensing
More informationReview of Controlled Drugs and Substances Act
Review of Controlled Drugs and Substances Act Canadian Medical Association: Submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations A
More informationSupplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016.
CAYMAN ISLANDS Supplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016. A BILL FOR A LAW TO AMEND THE MISUSE OF DRUGS LAW (2014 REVISION) TO INCLUDE CANNABIS EXTRACTS AND
More informationSUBJECT: Effective Date: Policy Number: Controlled Substance and Prescription Drugs 11/30/
Division of Research SUBJECT: Effective Date: Controlled Substance and Prescription Drugs 11/30/2018 Supersedes: Page Of 12/04/2015 04/25/2007 1 6 Responsible Authorities: Vice President, Research Institutional
More informationPART 1306 PRESCRIPTIONS. 21 CFR Ch. II ( Edition)
1305.16 1305.16 Special procedure for filling certain order forms. (a) The purchaser of carfentanil etorphine hydrochloride or diprenorphine shall submit copy 1 and 2 of the order form to the supplier
More informationSummary of Related Documentation Pennsylvania House Bill 1846 of 2014
Summary of Related Documentation Pennsylvania House Bill 1846 of 2014 15 November 2018 Department of Labor & Industry BWC-Administrative Division 1171 S. Cameron St. Harrisburg PA 17104-2501 Essential
More informationTitle of Session: Restricting the Marketing and Advertising of Opioids in Canada Date of Session: September 5, 2018
Title of Session: Restricting the Marketing and Advertising of Opioids in Canada Date of Session: September 5, 2018 Purpose To update stakeholders on Health Canada s actions to date, and to consult on
More informationThe Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.
The Wisconsin Prescription Drug Monitoring Program Wisconsin Nurses Association Jail Health Care Conference May 21, 2018 WI PDMP Timeline PDMP Overview January 2013 WI PDMP operational April 2017 WI epdmp
More informationCase 8:14-cv DKC Document 2-4 Filed 11/17/14 Page 1 of 17. Exhibit 3
Case 8:14-cv-03607-DKC Document 2-4 Filed 11/17/14 Page 1 of 17 Exhibit 3 Case 8:14-cv-03607-DKC Document 2-4 Filed 11/17/14 Page 2 of 17 Mallinckrodt: Chart Documenting Generic Substitution Laws for 50
More information